sdj-10114

Diagnostic Potential of Salivary Biomarker Profiles in Epidemiological Survey of Periodontitis

Lona K. Mohammed* , Sarhang S. Gul*

* Periodontics Department, College of Dentistry, University of Sulaimani, Sulaimani, Iraq.

Submitted: 15/08/2020; Accepted: 30/08/2020; Published 01/12/2020

DOI: https://doi.org/10.17656/sdj.10114

Abstract

Objective: To assess the diagnostic value of salivary biomarker profiles in determining the prevalence of periodontitis in the adult population using the case definition for population-based surveillance of periodontitis (CDC/AAP) criteria.

Methods: Eighty subjects with healthy periodontium, mild, moderate, and severe periodontitis were recruited (20 in each group) using CDC/AAP criteria. Clinical parameters of probing pocket depth (PPD), clinical attachment loss (CAL), plaque index (PI), and bleeding index (BI) were recorded. Salivary samples were analyzed to determine levels of matrix metalloproteinase-8 (MMP8), interleukin 1β (IL-1β), and total protein (TP). ANOVA and Kruskal-Wallis tests were used to compare clinical and salivary parameters. Multinomial regression analysis was used to identify each examined group.

Results: Clinical parameters were significantly higher in periodontitis groups compared to the healthy group (p< 0.0001) except in PPD and PI. Both MMP8 and IL-1β were significantly higher in the moderate and severe periodontitis groups compared to the healthy group. No statistically significant differences in TP levels were found between examined groups (p=0.9). Multinomial regression analysis showed that the combination of MMP8, IL-1β, and age could accurately identify health, mild, moderate, and severe periodontitis groups with the certainty of 90%, 65%, 60%, 70%, respectively.

Conclusions: This study suggests that age, salivary MMP8, and IL-1β levels offer a way to determine the prevalence of periodontitis using CDC/AAP criteria.

Keywords: Periodontitis, diagnosis, prevalence, saliva, MMP8, IL-1β, prediction. Full Article - PDF

References:

1. Newman MG, Takei H, Klokkevold PR, Carranza FA. Carranza's clinical periodontology: Elsevier health sciences; 2011 .

2. Kassebaum N, Bernabé E, Dahiya M, Bhandari B, Murray CJL, Marcenes W. Global burden of severe periodontitis in 1990-2010: a systematic review and meta-regression. J Dent Res. 2014;93(11):1045-53 .

3. Dye BA. Global periodontal disease epidemiology. Periodontol 2000. 2012;58(1):10-25 .

4. Manakil J. Periodontal disease- a clinician's guide. Manakil J. Croatia Ivona Lovric; 2012 .

5. Bourgeois D, Bouchard P, Mattout C. Epidemiology of periodontal status in dentate adults in France, 2002–2003. J Periodontal Res. 2007;42(3):219-27 .

6. White D, Tsakos G, Pitts N, Fuller E, Douglas G, Murray J, et al. Adult dental health survey 2009: common oral health conditions and their impact on the population. Br Dent J. 2012;213(11):567-72.

7. Beltrán Aguilar ED, Eke PI, Thornton-Evans G, Petersen PE. Recording and surveillance systems for periodontal diseases. Periodontol 2000. 2012;60(1):40-53 .

8. Baelum V, López R. Defining aperiodontitis case: analysis of a never‐treated adult population. J Clin Periodontol. 2012;39(1):10-9.

9. Eke PI, Page RC, Wei L, Thornton-Evans G, Genco RJ. Update of the case definitions for population-based surveillance of periodontitis. J Periodontol. 2012;83(12):1449-54 .

10. Tonetti MS, Greenwell H, Kornman KS. Staging and grading of periodontitis: Framework and proposal of a new classification and case definition. J Periodontol. 2018;89(Suppl 1):S159 - S72 .

11. Miller CS, Foley JD, Bailey AL, Campell CL, Humphries RL, Christodoulides N, et al. Current developments in salivary diagnostics. Biomark Med. 2010;4(1):171-89 .

12. Alassiri S, Parnanen P, Rathnayake N, Johannsen G, Heikkinen A-M, Lazzara R, et al. The ability of quantitative, specific, and sensitive point-of- care/chair-side oral fluid immunotests for aMMP- 8 to detect periodontal and peri-implant diseases. Dis Markers. 2018; Article ID 1306396, 5 pages.

13. Gul SS, Douglas CWI, Griffiths GS, Rawlinson A. A pilot study of active enzyme levels in gingival crevicular fluid of patients with chronic periodontal disease. J Clin Periodontol. 2016;43(8):629-36.

14. Korte DL, Kinney J. Personalized medicine: an update of salivary biomarkers for periodontal diseases. Periodontol 2000. 2016;70(1):26–37.

15. Taylor JJ. Protein biomarkers of periodontitis in saliva. ISRN Inflamm. 2014:593151.

16. Preshaw PM, Taylor, JJ. How has research into cytokine interactions and their role in driving immune responses impacted our understanding of periodontitis?. J Clin Periodontol. 2011;38(Suppl 11):60-84.

17. Pereira SA, Melo A, Resende E, Regateiro F, Coimbra Silva H. Antagonistic effect of IL1 variants in periodontitis and external apical root resorption: evidence from a literature review. Arch Oral Biol. 2018;95:195-201.

18. Zhang L, Henson BS, Camargo PM, Wong DT. The clinical value of salivary biomarkers for periodontal disease. Periodontol 2000. 2009;51(1):25-37 .

19. Rai B, Kharb S, Jain R, Anand SC. Biomarkers of periodontitis in oral fluids. Oral Sci. 2008;50(1):53-6 .

20. Gursoy UK, Könönen E, Huumonen S, Tervahartiala T, Pussinen PJ, Suominen AL, et al. Salivary type I collagen degradation end‐products and related matrix metalloproteinases in periodontitis. J Clin Periodontol. 2013;40(1):18- 25.

21. Chaussain-Miller C, Fioretti F, Goldberg M, Menashi S. the role of matrix metalloproteinases (MMPs) in human caries. J Dent Res. 2006;85(1):22-32.

22. Mohammad CA. Effect of periodontal therapy on salivary total protein, TNF-alpha and IL-1 beta in chronic periodontitis patients. Sulaimani Dent J. 2018;5(1):16-22 .

23. Xiang X, Sowa MG, Iacopino AM, Maev RG, Hewko MD, Man A, et al. An update on novel non- invasive approaches for periodontal diagnosis. J Periodontol. 2010;81(2):186-98.

24. Ainamo J, Bay I. Problems and proposals for recording gingivitis and plaque. Int Dent J. 1975;25(4):229-35 .

25. Lindhe J, Socransky S, Nyman S, Haffajee A, Westfelt E. “Critical probing depths” in periodontal therapy. J Clin Periodontol. 1982;9(4):323-36 .

26. Badersten A, Nilvéus R, Egelberg J. Reproducibility of probing attachment level measurements. J Clin Periodontol. 1984;11(7):475–85.

27. Navazesh M. Methods for collecting saliva. Ann N Y Acad Sci. 1993;694(1):72-7.

28. Tietz N. Measurement of total protein-Biuret method. Text book of clinical chemistry. Elseiver Publishers; 2005 .

29. Ghallab NA. Diagnostic potential and future directions of biomarkers in gingival crevicular fluid and saliva of periodontal diseases: review of the current evidence. Arch Oral Biol. 2018;87:115–24.

30. Isaza-Guzmán DM, Medina-Piedrahíta VM, Gutiérrez-Henao C, Tobón-Arroyave SI. Salivary Vol 7(2) Mohammed and Gul 44 levels of NLRP3 inflammasome-related proteins as potential biomarkers of periodontal clinical status. J Periodontol. 2017;88(12):1329-38.

31. Wu YC, Ning L, Tu YK, Huang CP, Huang NT, Chen YF, Chang PC. Salivary biomarker combination prediction model for the diagnosis of periodontitis in a Taiwanese population. J Formos Med Assoc. 2018;117(9):841-48.

32. Kc S, Wang XZ, Gallagher JE. Diagnostic sensitivity and specificity of host-derived salivary biomarkers in periodontal disease amongst adults: Systematic review. J Clin Periodontol. 2020;47(3):289-08.

33. Buduneli N. Biomarkers for periodontal diseases. In: biomarkers in periodontal health and disease. 2020, Springer, Cham.

34. Lee YH, Wong DT. Saliva: an emerging biofluid for early detection of diseases. Am J Dent. 2009;22(4):241-48.

35. Salminen A, Gursoy UK, Paju S, Hyvärinen K, Mäntylä P, Buhlin K, et al. Salivary biomarkers of bacterial burden, inflammatory response, and tissue destruction in periodontitis. J Clin Periodontol. 2014;41(5):442-50.

36. Kinney JS, Morelli T, Braun T, Ramseier CA, Herr AE, Sugai JV, et al. Saliva/pathogen biomarker signatures and periodontal disease progression. J Dent Res. 2011;90(6):752-8.

37. Arias-Bujanda N, Regueira-Iglesias A, Blanco- Pintos T, Alonso-Sampedro M, Relvas M, González-Peteiro MM, et al. Diagnostic accuracy of IL1β in saliva: the development of predictive models for estimating the probability of the occurrence of periodontitis in non-smokers and smokers. J Clin Periodontol. 2020. doi: 10.1111/jcpe.13285.

38. Jaedicke KM, Preshaw PM, Taylor JJ. Salivary cytokines as biomarkers of periodontal diseases. Periodontol 2000. 2016;70(1):164-83.

39. Lee JY, Chung JW, Kim YK, Chung SC, Kho HS. Comparison of the composition of oral mucosal residual saliva with whole saliva. Oral Dis. 2007;13(6):550-4.

This work is licensed under a Creative Commons Attribution 4.0 International License.